Current companies
Pharmaceutical company in Phase II
The company is developing a pharmaceutical candidate for a life-threatening disease for which there is currently no sufficient treatment. The candidate is in the clinical studies Phase II and the company expects to be acquired in 2020.
Capitalisation through a private placement.
Contact us for more information.
Technology company within DNA sequencing
The company operates within DNA sequencing and has developed a solution providing significantly improved performance compared with today’s solutions. The market is growing rapidly in terms of both research and clinical applications. The company expects to be acquired during 2020 after achievement of specific product development milestones.
Capitalisation through a private placement.
Contact us for more information.
Sciety is a digital investment network
Sciety combines medical and business competence to select promising growth companies in the life science sector. We give you the opportunity to invest in unlisted companies within digital health, medical technology and more.
Qualified companies
Sciety takes care of selection and vetting, and manages the complete investment process. We offer investment opportunities in companies with the potential to give return on investment and make a difference.
Straightforward to invest
As a member, you will find all investment information online and you will also be invited to meet with the companies at our investor lunches.
Selling the share
Invest online and free of charge. You will own your shares directly in the companies and join their expansion. We focus on companies with clear exit plans.
News
Sciety arranges two private placements
Sciety is currently capitalising, via private placements, one pharmaceutical company in Phase II and a biotech company working with DNA sequencing. These companies operate in strong growth markets and are…
Läs merNew venture at Sciety – develops drugs for diseases caused by high levels of blood lipids
Lipid imbalances does not only cause common diseases such as diabetes and cardiovascular diseases but also various rare diseases. The pharma company Lipigon is specialised in diseases caused by lipid…
Läs merInvest with us
Sciety gives members the opportunity to invest in unlisted growth companies with the potential to give return on investment and make a difference. We specialise in the life science sector.